Repeat(Ab)le Epigenetics Antibodies We know repetition is a part of the Scientific Method. But because our antibody development process minimizes lot-to-lot variation, you can publish your results with confidence. Looking for a new antibody? Having issues with your current antibody? Find the most reliable antibody for your research. Take the Antibody Challenge! Three easy steps: 1. Tell us about your antibody needs (protein antigen, species reactivity and application). 2. Challenge us to find a remarkable and validated antibody that meets your needs. 3. Receive a Special Discount to try the antibody. EMD Millipore has developed technology that addresses three pivotal areas of epigenetics research that are playing substantial roles in the control of epigenetic gene expression and inheritance: DNA methylation, histone modification, and—more recently—RNA-associated gene silencing events and modification, now called RNA epigenetics. We offer an extensive, focused portfolio of antibodies and immunoassays, including validated antibodies for effective immunoprecipitation of chromatin, RNA-binding proteins, modified histones, and transcriptional proteins. Advance your Epigenetics Research with ChIPAb+™ and RIPAb+™ Validated Antibody and primer sets www.emdmillipore.com/epigenetics EMD Millipore Corp. is a subsidiary of Merck KGaA, Darmstadt, Germany Confocal immunocytochemistry fluorescent analysis of NIH/3T3 cells (top rows) and A431 cells (bottom row). Positive nuclear staining with Anti-acetyl-Histone H3 Ab (06-599, red). Actin filaments labeled with AlexaFluor®488 Phalloidin (green). Nuclear staining with DAPI (blue).